Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from ImExHS Limited ( (AU:IME) ).
ImExHS Limited has scheduled the release of its FY25 financial results for 27 February 2026, covering the year ended 31 December 2025. The company will follow this with an investor presentation led by CEO and Co-Founder Dr German Arango and CFO Reena Minhas on 3 March 2026 at 11:00am AEST.
The results briefing, accessible via pre-registration, is positioned as a key communication touchpoint for shareholders and stakeholders to gain insight into IMEXHS’s recent performance. It also reinforces the company’s ongoing investor engagement as it continues to scale its cloud-based medical imaging and radiology services platform across multiple international markets.
The most recent analyst rating on (AU:IME) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
IMEXHS Limited is an Australian-listed provider of medical imaging software and radiology services operating in 18 countries. Founded in 2012, the company delivers cloud-based, vendor-neutral SaaS solutions including PACS, RIS, CIS and APLIS platforms designed to improve productivity, reduce costs and enhance patient outcomes for healthcare providers.
Average Trading Volume: 30,380
Technical Sentiment Signal: Hold
Current Market Cap: A$24.32M
For a thorough assessment of IME stock, go to TipRanks’ Stock Analysis page.